The human immunodeficiency virus (HIV) gag gene encodes the viral structural protein Gag, which is translated initially as a precursor Pr55 gag (Wills & Craven, 1991; Hunter, 1994) . Pr55 gag is transported to the plasma membrane where several thousand Pr55 gag molecules assemble into virus particles that bud out from the cell membrane.
During or after virus budding, Pr55
gag is cleaved by the viral pol-encoded protease (PR) into four major proteins: matrix (MA; p17), capsid (CA; p24), nucleocapsid (NC; p7) and the C-terminal p6 (Erickson-Viitanen et al., 1989; Freed, 1998; Henderson et al., 1992; Kaplan et al., 1994; Leis et al., 1988; Mervis et al., 1988; Swanstrom & Wills, 1997) . The gag and pol coding sequences partially overlap. A 21 ribosomal frameshift event occurs at a frequency of about 5 % during gag translation, resulting in Pol being translated as a GagPol fusion protein (Jacks et al., 1988) . Within the Gag-Pol, the p6 domain is truncated and replaced by a transframe domain referred to as p6* or p6
pol (Partin et al., 1990) . Proteolytic processing of Gag-Pol by the PR yields reverse transcriptase (RT), RNase H and integrase (IN) in addition to the Gag cleavage products. The PR-mediated virus maturation process is not required for virus assembly and budding, but is essential for viral infectivity (Gottlinger et al., 1989; Kohl et al., 1988; Peng et al., 1989) .
How the PR is activated to mediate Gag particle maturation is still not completely understood. It is thought that dimerization of Gag-Pol is a prerequisite for PR activation (Navia & McKeever, 1990) . The activated PR then cleaves itself out from Gag-Pol and functions as a homodimer to process Gag and Gag-Pol. An in vitro study has suggested that sequences flanking the PR domain may contribute to the process of PR activation (Louis et al., 1999; Pettit et al., 2003; Wondrak & Louis, 1996) . Several other studies have also demonstrated that HIV-1 Gag-Pol molecules lacking the gag coding sequence or truncated in the RT domain are significantly defective in autoprocessing or in trans processing of Gag particles (Engelman et al., 1995; Liao & Wang, 2004; Quillent et al., 1996; Zybarth & Carter, 1995) . Thus, sequences downstream or upstream of PR may potentially affect the PR activity, presumably via facilitating formation of a proper Gag-Pol dimer, which is thought to be required for activating the embedded PR.
The p6* domain is located directly N-terminal to the PR and separates NC from Pol. One previous study demonstrated that the removal of the p6* improves the proteolytic processing of Gag-Pol in vitro, suggesting an inhibitory effect of p6* on PR activation (Partin et al., 1991) . In support of this notion, mutations preventing cleavage of p6* from the PR have been shown to markedly impair PR-mediated Gag processing (Chen et al., 2004; Tessmer & Krausslich, 1998; Zybarth et al., 1994) . Additionally, synthetic p6* peptides have been reported to be able to suppress PR activity in vitro (Louis et al., 1998; Paulus et al., 1999) . These results strongly suggests that the presence of p6* may interfere with the functioning of PR, and that p6* does not appear to make a positive contribution to the process of PR activation.
To investigate the role of the HIV-1 p6* domain in PRmediated virus particle processing, deletion mutations in p6* were engineered by the two-megaprimer PCR extension method (Sambrook & Russell, 2001 ) using HIVgpt, which carries the SV40 ori and gpt (xanthine-guanine phosphoribosyltransferase) genes in the env region (Page et al., 1990) , or a Pr160 gag-pol -expression plasmid, GPfs (Chiu et al., 2002) as template. Primer sequences and detailed procedures for creating the mutations are available on request. Wild-type GPfs or each of the GPfs mutants ( Fig. 1 ) was coexpressed with a Pr55 gag expression plasmid, pGAG, in 293T cells. At 48 h post-transfection, culture medium from transfected 293T cells was filtered through 0?45 mm pore-size filters, followed by centrifugation through 2 ml 20 % sucrose in TSE [10 mM Tris/HCl (pH 7?5), 100 mM NaCl, 1 mM EDTA] plus 0?1 mM PMSF at 4 u C for 40 min at 274 000 g (SW41 rotor at 40 000 r.p.m.). The cells were rinsed with ice-cold PBS, pelleted, and were resuspended in 250 ml immunoprecipitation buffer plus 0?1 mM PMSF, and then subjected to microcentrifugation at 4 u C for 15 min at 13 700 g to remove cell debris. Supernatant and cell samples were prepared and subjected to Western immunoblot analysis as described previously (Wang et al., 1998) . When cotransfected with pGAG plasmid at a DNA ratio of 1 : 10, both D2fs and D3fs exhibited a virus particle processing pattern similar to that of wild-type (wt) GPfs, with mature p24 gag representing the major species of virus-associated Gag products (Fig. 2a, lanes 15 and 17) . In contrast, D1fs produced a total amount of unprocessed and incompletely processed Gag slightly higher than that of wt (Fig. 2a, lanes 13 vs 11 and Fig. 2c , lanes 15 vs 13), suggesting that PR-mediated particle processing has been affected when most of the p6* codons were removed. However, virus particle production was markedly reduced or abolished when the amount of plasmid DNA of the wt GPfs or p6* deletion mutants used for cotransfection was equivalent to that of pGAG (Fig. 2a, lanes 10, 12, 14 and 16 ). This indicates that when both wt and mutant GPfs are overexpressed they can efficiently suppress virus budding, presumably due to premature cleavage of Gag precursors by Gag-Pol (Arrigo & Huffman, 1995; Burstein et al., 1991; Krausslich, 1991; Park & Morrow, 1991; Rose et al., 1995; Wang et al., 2000; Xiang et al., 1997) .
The results shown above do not support the proposal that removal of the p6* can improve PR activity. On the contrary, it seems that the PR-mediated particle processing was somewhat impaired by the p6*-deleted mutation under a near normal physiological condition. Since previous studies have suggested that the upstream gag sequence may affect the PR-mediated Gag processing (Chiu et al., 2002; Zybarth et al., 1995) it was of interest to test the effects of a p6*-deleted mutation on PR-mediated virus processing in a Gag-Pol context containing a whole intact (p6 gag /p6*Pol, p6 gag /Pol) or deleted Gag domain [DGAG, D(GAG+p6*); Fig. 1 ]. Unlike DGAG, which could still produce virusassociated p24 gag (Fig. 2b, lane 12) , D(GAG+p6*) was severely defective in proteolytic processing of Pr55 gag , as no mature p24 gag was detected in either medium or cell lysates (Fig. 2b, lanes 6 and 13) . Despite being cotransfected with a higher amount of plasmid DNA, D(GAG+p6*) still could not produce p24/25 gag ; instead, a trace amount of p41 gag was observed (Fig. 2b, lanes 3 and 10) . This suggests that PR-mediated Gag processing was almost abrogated by the D(GAG+p6*) mutation. In contrast, the p6
gag /p6*Pol demonstrated a Gag particle processing profile similar to that of wt GPfs when cotransfected with pGAG at a DNA ratio of either 1 : 10 or 1 : 1 (Fig. 2c, lanes 16-17 vs 12-13) . However, the p6 gag /Pol was markedly defective in Gag particle processing, as substantial amounts of Gag proteins remained in the precursor or intermediate forms (Fig. 2c,  lane 19) . Overexpression of p6 gag /Pol does not suppress virus particle production as efficiently as the GPfs or p6 gag / p6*Pol (Fig. 2c, lanes 18 vs 12 and 16) . These results suggests that the damage of p6*-deletion mutation to PR-mediated Gag processing is accentuated in the presence of additional mutations.
Although it is thought that the incorporation of HIV GagPol into virus particles depends on interactions with the Pr55 gag through its N-terminal Gag domain, it is unknown whether mutations in p6* can affect the incorporation of Gag-Pol into virus particles. To test whether p6* deletion mutations have any detrimental effect on Gag-Pol incorporation, which may consequently impair viral infectivity, aliquots of the culture medium used for infection were measured for virus-associated RT by Western blot. The results shown in Fig. 2(d) suggest that the p6* deletion mutations have no significant effect on the incorporation of Gag-Pol into virions, as D1fs, D2fs and D3fs all produced a level of virus-associated p66/51 RT comparable to that of wt GPfs (Fig. 2d, lanes 3-6) . However, in addition to relatively higher levels of unprocessed and incompletely processed Gag, trace amounts of Pr160 gag-pol precursors were readily detected in virions produced from cotransfections with D1fs (Fig. 2d, lane 4) . This supports the proposal that the D1 mutation has impaired PR activity. The results shown above suggest that our p6* deletion mutations in Gag-Pol have no major or only a modest effect on PR-mediated particle processing. Since the PR-mediated virus maturation process is a prerequisite for viral infectivity, immature or inappropriately processed virus particles ought to lose infectivity. We performed a single-cycleinfection assay to measure how the p6* deletion mutations affected viral infectivity. To do so, the wt GPfs or each of the mutant GPfs constructs was cotransfected with the pGAG plus a vesicular stomatitis virus glycoprotein expression vector, pHCMV-G (Yee et al., 1994) . At 48-72 h, culture supernatants of transfected 293T cells were collected and the filtered supernatants were used to infect HeLa cells, which had been split and grown to 20 % confluence at the time of infection. Adsorption of virus was allowed to proceed at 37 uC in the presence of 4 mg Polybrene ml
21
. Two days after infection, the cells were trypsinized and split 1 : 10 into 10 cm dishes containing selection medium (50 mg xanthine ml 21 , 3 mg hypoxanthine ml 21 , 4 mg thymidine ml
, 10 mg glycine ml 21 and 150 mg glutamine ml
) plus 25 mg mycophenolic acid (Gibco) ml 21 (Chen et al., 1997) . Ten to 14 days later, colonies of drug-resistant cells were fixed and stained with 0?5 % methyl blue in 50 % methanol. Drug-resistant colonies were converted to titres (infectious units ml 21 ) and normalized to the corresponding virusassociated Gag protein level. As shown in Fig. 3(b) , the infectivity of virions produced from cotransfections with D1fs or D2fs is markedly reduced, with viral infectivity at 20-50 % relative to that of wt GPfs. In contrast, D3fs could produce virus particles with a level of infectivity comparable to that of wt GPfs. HIVgptD3 showed an infectivity level of about 80 % compared with the wt (Fig. 3a) , which agrees with previous reports that suggest deletions in this region do not significantly affect HIV-1 replication (Bleiber et al., 2004; Paulus et al., 2004) . In the case of cotransfection with p6 gag /p6*Pol, the infectivity of the released virions was only about 10 % relative to wt GPfs, although the virus particles were processed as well as those produced from the wt GPfs cotransfection (Fig. 2c, lanes 17 vs 13) . These results suggest that a significant portion of the processed virions from cotransfections with Gag-Pol mutants were noninfectious. Functional interference in the post-assembly post-processing stage of virus replication by the p6 gag embedded in the incorporated Gag-Pol may account in part for the reduced viral infectivity. The defect in viral particle processing is certainly able to impair viral infectivity. However, efficient PR-mediated virus processing is necessary but not sufficient for viral infectivity since several other factors may affect viral infectivity. For instance, the incorporated Gag-Pol mutants may have an impact on proper Gag assembly, and consequently interfere with virus replication. Additionally, tRNA incorporation (Mak et al., 1994) or the stability of genomic RNA dimer (Shehu-Xhilaga et al., 2001) may be influenced by the Gag-Pol mutants, resulting in reduced viral infectivity. This may possibly explain why D1fs, which is unable to process virus particles as well as the wt and contains a near wt level of RT, produced virions with infectivity reduced to only 20 % relative to that of the wt.
In conclusion, our results strongly suggest that the presence of p6* is essential during the process of PR-mediated Gag cleavage. It is clear that p6* may have a contribution to make in facilitating Gag-Pol dimerization or in stabilizing the Gag-Pol dimer, which is required for the induction of the activation of embedded PR; however, removal of the p6* may eventually be necessary to allow the freed PR to become fully functional. gag-pol mutants and pGAG plus pHCMV-G. 293T cells were either (a) cotransfected with 10 mg wild-type (wt) or the mutant HIVgpt D3 and 5 mg pHCMV-G, or (b) cotransfected with 1 mg of the GPfs or the GPfs version of the designated plasmid with 10 mg pGAG plus 5 mg pHCMV-G. At 48-72 h after transfection, supernatants were used to infect HeLa cells. Infection and selection of drugresistant colonies were as described in the text. Viral titre per Gag protein unit for each mutant was plotted relative to that of wt HIVgpt or GPfs in parallel experiments. Data were obtained from at least three independent experiments with different DNA, or at different times, or both.
